EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma

Christina Bluemel, Ken Herrmann, Francesco Giammarile, Omgo E Nieweg, Julien Dubreuil, Alessandro Testori, Riccardo A Audisio, Odysseas Zoras, Michael Lassmann, Annette H Chakera, Roger Uren, Sotirios Chondrogiannis, Patrick M Colletti, Domenico Rubello

89 Citationer (Scopus)


PURPOSE: Sentinel lymph node biopsy is an essential staging tool in patients with clinically localized melanoma. The harvesting of a sentinel lymph node entails a sequence of procedures with participation of specialists in nuclear medicine, radiology, surgery and pathology. The aim of this document is to provide guidelines for nuclear medicine physicians performing lymphoscintigraphy for sentinel lymph node detection in patients with melanoma.

METHODS: These practice guidelines were written and have been approved by the European Association of Nuclear Medicine (EANM) to promote high-quality lymphoscintigraphy. The final result has been discussed by distinguished experts from the EANM Oncology Committee, national nuclear medicine societies, the European Society of Surgical Oncology (ESSO) and the European Association for Research and Treatment of Cancer (EORTC) melanoma group. The document has been endorsed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

CONCLUSION: The present practice guidelines will help nuclear medicine practitioners play their essential role in providing high-quality lymphatic mapping for the care of melanoma patients.

TidsskriftEuropean Journal of Nuclear Medicine and Molecular Imaging
Udgave nummer11
Sider (fra-til)1750-66
Antal sider17
StatusUdgivet - okt. 2015


Dyk ned i forskningsemnerne om 'EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma'. Sammen danner de et unikt fingeraftryk.